Menu


- Home
- Expertise
- What we do
- What we have
- Who we are
- Resource Library
When you are in the process of developing a new drug or indication for your existing therapy, it will be helpful to gain insight into the potential patient population. With our data we can describe several aspects of the epidemiology of disease, including the incidence and prevalence over time or in specific subpopulations. For more information, click here.
Ref. Overbeek J, van den Berg E, Penning-van Beest F, et al. Incidence and prevalence of COPD by GOLD 2013 classification in the Netherlands. Pharmacoepidemiol Drug Saf, 2015; 24 (S1): 367-368